Science
Mechanism of Action
Methyl Undecylenoyl Dipeptide-16, a modified derivative, precisely targets the Melanocortin 1 Receptor (MC1R). By competitively binding to MC1R and displacing its natural ligand, alpha-MSH, it effectively deactivates a cascade of melanogenic genes, including tyrosinase, TRP1, TRP2 (DCT), MITF, and POMC, thereby blocking melanin overproduction. Furthermore, it demonstrates an additional benefit by reducing UVB-induced inflammatory responses, contributing to a significant photoprotective effect.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Peptide stability is intrinsically pH-dependent; extreme pH environments (acidic pH 1-3 or alkaline pH > 7) can instigate degradation pathways such as hydrolysis or epimerization. A neutral to slightly acidic pH range is generally considered optimal for preserving peptide integrity. The specific optimal pH for DIPEPTIDE-16 is not precisely defined. Its 'Methyl Undecylenoyl' modification is a strategic enhancement, increasing lipophilicity to improve skin penetration and integrate well into various formulation types.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) has not yet assessed DIPEPTIDE-16. No specific SCCS or FDA cosmetic status reports were identified for this ingredient. However, rigorous dermatological tolerance testing of Methyl Undecylenoyl Dipeptide-16 has consistently shown an absence of cytotoxic effects, irritation, or sensitization reactions in healthy volunteers, indicating a low risk profile.
Your Skin
Skin Compatibility
Our Assessment
Verdict
DIPEPTIDE-16 is a valuable multi-functional peptide, effectively addressing hyperpigmentation, signs of aging, and photoprotection with a demonstrated high safety profile and broad skin compatibility.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources